A panel of tumour markers including carcinoembryonic antigen (CEA), carbohydrate antigen (Ca)15-3, Cal 25 and Ca19-9 were measured in the lysate of sediments and in the supernatants of pleural effusions of patients with benign and malignant disease The tumour markers were also measured in the serum of the same patients Of these patients, 32 had benign diseases (12 trasudative effusions associated with cirrhosis and 20 with non-malignant exudates 12 pleuritis and 8 other inflammations) and 103 had malignant effusions (37 breast cancers, 29 lung cancers, 10 ovary cancers, 6 kidney cancers, 11 mesotheliomas and 10 lymphomas) We showed the highest level of CEA in pleural effusions of lung cancer followed by that in pleural effusions of breast cancer, whereas Ca15-3 was very high in the pleural effusions of breast and lung cancer Concerning the lysate of sediment, CEA was high in the pleural effusions of patients with lung cancer and Ca15-3 in those of patients with breast cancer The other markers are much less useful For the remaining tumours, none of the markers tested appear to aid in the diagnosis of disease In conclusion, our data suggest that the combined determination of tumour markers on supernatants and sediments of pleural effusion may provide additional information on the nature of pleural effusion, especially for cases with negative cytology

Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions / D., Terracciano; C., Mazzarella; M., Cicalese; S., Galzerano; G., Apostolico; DI CARLO, Angelina; A., Mariano; C., Cecere; V., Macchia. - In: ONCOLOGY LETTERS. - ISSN 1792-1074. - 1:3(2010), pp. 465-471. [10.3892/ol_00000082]

Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions

DI CARLO, ANGELINA;
2010

Abstract

A panel of tumour markers including carcinoembryonic antigen (CEA), carbohydrate antigen (Ca)15-3, Cal 25 and Ca19-9 were measured in the lysate of sediments and in the supernatants of pleural effusions of patients with benign and malignant disease The tumour markers were also measured in the serum of the same patients Of these patients, 32 had benign diseases (12 trasudative effusions associated with cirrhosis and 20 with non-malignant exudates 12 pleuritis and 8 other inflammations) and 103 had malignant effusions (37 breast cancers, 29 lung cancers, 10 ovary cancers, 6 kidney cancers, 11 mesotheliomas and 10 lymphomas) We showed the highest level of CEA in pleural effusions of lung cancer followed by that in pleural effusions of breast cancer, whereas Ca15-3 was very high in the pleural effusions of breast and lung cancer Concerning the lysate of sediment, CEA was high in the pleural effusions of patients with lung cancer and Ca15-3 in those of patients with breast cancer The other markers are much less useful For the remaining tumours, none of the markers tested appear to aid in the diagnosis of disease In conclusion, our data suggest that the combined determination of tumour markers on supernatants and sediments of pleural effusion may provide additional information on the nature of pleural effusion, especially for cases with negative cytology
2010
carbohydrate antigen 125; carbohydrate antigen 15-3; carcinoembryonic antigen; pleural effusions
01 Pubblicazione su rivista::01a Articolo in rivista
Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions / D., Terracciano; C., Mazzarella; M., Cicalese; S., Galzerano; G., Apostolico; DI CARLO, Angelina; A., Mariano; C., Cecere; V., Macchia. - In: ONCOLOGY LETTERS. - ISSN 1792-1074. - 1:3(2010), pp. 465-471. [10.3892/ol_00000082]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/12685
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact